newsfilter
← Latest News
GlobeNewswire·

Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study

Clear Improvement in Patient's Skin Appearance Observed in Study after 12 weeks Compared to BaselineKey endpoints including Investigator's Global Assessment (IGA), Modified Ichthyosis Area Severity (M-IASI) and